Pipazetate (INN) and its salts
Listed by the Saudi Food and Drug Authority as prohibited in cosmetic products.
监管决定及完整条件
- 状态
- Prohibited
- 法律地位
- Binding rule
- 监管摘要
- Listed by the Saudi Food and Drug Authority as prohibited in cosmetic products.
- 条件与限制
- A prohibition entry may contain no separate condition text because the regulatory outcome is the prohibition itself. 请打开所引用的来源,并适用下方的全市场要求。
物质身份
- 官方来源名称
- Pipazetate (INN) and its salts
- CAS
- 2167-85-3
- EC
- Not supplied in this source row
- 身份映射
- standalone:official_sfda_record
该身份的跨市场概览
本站目前已有的精确关联记录。某市场缺失表示没有已导入的精确匹配,并不表示准许使用该物质。
European Union
1 条关联记录
打开支持记录Great Britain
1 条关联记录
打开支持记录Canada
1 条关联记录
打开支持记录New Zealand
1 条关联记录
打开支持记录ASEAN
1 条关联记录
打开支持记录China
1 条关联记录 · 1 条含特定条件
打开支持记录South Korea
1 条关联记录 · 1 条含特定条件
打开支持记录Brazil
1 条关联记录 · 1 条含特定条件
打开支持记录India
1 条关联记录 · 1 条含特定条件
打开支持记录Saudi Arabia
当前记录1 条关联记录
打开支持记录
CAS 2167-85-3 的已核实化学信息
Pipazethate
Pipazetate is an aryl sulfide. — ChEBI
- IUPAC 名称
- 2-(2-piperidin-1-ylethoxy)ethyl pyrido[3,2-b][1,4]benzothiazine-10-carboxylate
- 分子式
- C21H25N3O3S
- 分子量
- 399.5 g/mol
- 精确质量
- 399.16166284 Da
- 单同位素质量
- 399.16166284 Da
- XLogP3
- 3.4
- 拓扑极性表面积
- 80.2 Ų
- 分子复杂度
- 503.0
- 形式电荷
- 0
- 氢键供体
- 0
- 氢键受体
- 6
- 可旋转键
- 7
- 重原子
- 28
- 共价单元
- 1
向 PubChem 报告的名称和同义词
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:135635
- ChEMBL:CHEMBL2104900
- EPA DTXSID:DTXSID40176056
- PubMed:22291486
- PubMed:18483573
- PubMed:18410679
- PubMed:17580620
- PubMed:17142094
- PubMed:17092767
- PubMed:11708072
- PubMed:11489383
- PubMed:11205518
高级结构统计
- 已定义的原子立体中心
- 0
- 未定义的原子立体中心
- 0
- 已定义的键立体中心
- 0
- 未定义的键立体中心
- 0
- 三维药效团特征
- 8
- 三维环
- 4
- 三维疏水基团
- 0
- 三维受体特征
- 3
- 三维供体特征
- 0
- 三维阴离子中心
- 0
- 三维阳离子中心
- 1
- 三维构象异构体
- 10
- 有效三维可旋转键
- 9.6
机器可读的结构标识符
- SMILES
C1CCN(CC1)CCOCCOC(=O)N2C3=CC=CC=C3SC4=C2N=CC=C4- InChI
InChI=1S/C21H25N3O3S/c25-21(27-16-15-26-14-13-23-11-4-1-5-12-23)24-17-7-2-3-8-18(17)28-19-9-6-10-22-20(19)24/h2-3,6-10H,1,4-5,11-16H2- InChIKey
DTVJXCOMJLLMAK-UHFFFAOYSA-N
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
官方来源与出处
- 已登记来源
- Saudi SFDA prohibited and restricted ingredient lists
- 来源参考
- SFDA prohibited list, page 12, row 10
- 来源记录 ID
prohibited-11-10- 来源版本
- live-snapshot-2026-08-30
- 来源语言
- English
- 翻译状态
- Original is English
- 快照检查时间
- 2026-08-30 05:18 UTC
- 验证方法
- complete SFDA paginated HTML snapshot; strict page/row counts
- SHA-256
ceb6cc636e6b1f4b3013f88ce0297217b49d6194342c6ece5c03b1e04256d71a
已登记的数据集备注
- 数据集覆盖范围
- Prohibited and restricted substances with CAS, EC and conditions
- 权威性说明
- Official SFDA dated lists; version and hash each release
本记录在市场数据集中的位置
Saudi Arabia 市场背景
Complete official list index
覆盖版本: SFDA live prohibited/restricted lists, snapshot 30 August 2026
Every page and entry in the public SFDA prohibited and restricted ingredient indexes; restricted detail pages remain the source for conditions.
核实清单
- Search names and CAS across both SFDA lists.
- Open the cited restricted-entry detail and apply every condition.
- Check current SFDA/GSO technical regulations and updates.
- Complete eCosma notification, label and responsible-party requirements.
官方市场来源
- Saudi SFDA prohibited and restricted ingredient listsOfficial SFDA dated lists; version and hash each release
核实工作流程与记录完整性
在将此结果用于合规决定之前
- 确认“Pipazetate (INN) and its salts”及每个 CAS/EC 标识符所指的物料与您的供应商规格一致。
- Search names and CAS across both SFDA lists.
- Open the cited restricted-entry detail and apply every condition.
- Check current SFDA/GSO technical regulations and updates.
- Complete eCosma notification, label and responsible-party requirements.
- 记录来源版本,并在生产、备案或上市之前重新核查监管机构。
本记录中的可用字段
- 官方物质名称可用
- CAS可用
- EC未提供
- 单独的条件文本来源行中不存在
- 生效日期未提供
- 快照哈希与方法可用
本页回答的问题
稳定引用
Pipazetate (INN) and its salts. SFDA prohibited list, page 12, row 10. Saudi Arabia. Source version live-snapshot-2026-08-30. CosIng Checker regulatory record: https://cosingchecker.com/zh-hans/regulations/sa/records/9719/
请将监管机构作为法律依据来引用。本页是结构化的证据索引和核实辅助工具,不能替代官方文本或专业法律评估。
Saudi Arabia 的解读与局限
This official record identifies the substance as prohibited for cosmetic use in the stated market scope.
Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.
如何解读法律地位
The cited row forms part of a binding rule or legally incorporated list for this market.
本页证据
- 记录结果:Prohibited
- 法律地位:Binding rule
- 来源版本:live-snapshot-2026-08-30
它不能证明什么
No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply.
进一步的权威物质研究
这些来源均不能推翻上述市场决定。
Cosmetic Ingredient Review safety assessments
Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents
Independent expert review considered by FDA; not a government approval or binding market rule
在来源处研究此身份FDA Global Substance Registration System
UNII identifiers, preferred names, substance types, codes and public substance relationships
Identity registry only; UNII availability does not imply FDA review or approval
在来源处研究此身份ILO/WHO International Chemical Safety Cards
Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals
International occupational chemical-safety reference; not cosmetic-use approval
在来源处研究此身份Japan NITE-CHRIP
Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information
Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules
在来源处研究此身份NIOSH Pocket Guide to Chemical Hazards
REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals
US occupational-health guidance and limits; not a cosmetic ingredient decision
在来源处研究此身份OECD eChemPortal
Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records
Discovery gateway; each linked authority remains responsible for its data
在来源处研究此身份US EPA CompTox CTX APIs
导入需要 API 密钥DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data
Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality
在来源处研究此身份